Picture of Mirati Therapeutics logo

MRTX — Mirati Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Press Digest: Wall Street Journal - Oct. 9

Oct 9 (Reuters) - Following are the top stories in the
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.
    
    - Nelson Peltz's Trian Fund Management has increased its
stake in Disney  DIS.N  and the activist investor is expected to
request multiple board seats, including for himself.
    
    - Bristol Myers Squibb  BMY.N  has said it will acquire
Mirati Therapeutics  MRTX.O  in a transaction that values the
oncology developer at up to $5.8 billion.
    
    - Republicans in the U.S. House of Representatives face new
pressure to select a speaker after Israel declared war on
Sunday, following a rare attack by Hamas militants that has
prompted calls for more U.S. military aid.
    
    
        
  
        
  

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))

Recent news on Mirati Therapeutics

See all news